Flumatinib, 98%, 100mg
$399.00
In stock
SKU
Q833
Flumatinib / HHGV678 is a selective inhibitor of BCR-ABL/PDGFR/KIT. Flumatinib is currently in Phase I and II clinical trials in China for the treatment of chronic myelogenous leukemia (CML). Flumatinib effectively overcomes drug resistance of certain KIT mutants. Flumatinib mesylate can reduce the expression of C-MYC, HIF-1 α and VEGF in U266 cell line in a time- and dose-dependent manners.
THIS PRODUCT IS NOT FOR HUMAN USE
This Product Is For Research Use Only
Cat#: Q833
Name: Flumatinib free base
CAS#: 895519-90-1 (free base)
Chemical Formula: C29H29F3N8O
Molecular Weight: 562.59
Appearance:White to off-white solid powder
Purity:>98%
Delivery within 3-7 Days
For Bulk quantities,
Write Your Own Review